Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calavo Growers (CVGW) Accumulated Expenses (2016 - 2026)

Calavo Growers (CVGW) has 16 years of Accumulated Expenses data on record, last reported at $21.2 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 226.72% year-over-year to $21.2 million; the TTM value through Oct 2025 reached $21.2 million, up 226.72%, while the annual FY2025 figure was $21.2 million, 226.72% up from the prior year.
  • Accumulated Expenses reached $21.2 million in Q4 2025 per CVGW's latest filing, up from $10.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $51.9 million in Q1 2023 and bottomed at $6.5 million in Q4 2024.
  • Average Accumulated Expenses over 5 years is $33.8 million, with a median of $41.4 million recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: tumbled 69.48% in 2023, then soared 226.72% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $42.1 million in 2021, then increased by 23.14% to $51.8 million in 2022, then crashed by 69.48% to $15.8 million in 2023, then plummeted by 58.88% to $6.5 million in 2024, then skyrocketed by 226.72% to $21.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $21.2 million in Q4 2025, $10.5 million in Q3 2025, and $17.5 million in Q2 2025.